Ionis Pharmaceuticals Logo
Skip to content
  • About
    • Mission & Values
    • In The Community
    • Management
    • Board of Directors
    • Contact
  • R&D
    • Antisense Technology
      • Discovery Platform
      • Basic Science
      • Antisense Drugs
      • Medicinal Chemistry
      • Antisense Approaches
    • Intellectual Property
    • Strategic Alliances
      • Pharmaceutical Partners
      • Satellite Companies
  • Pipeline
  • Patients
    • Patient Resources
    • Clinical Trials
      • Drug Approval Process
  • Medical Professionals
    • ATTR Expanded Access Program
  • Investors & Media
    • News & Events
      • Press Releases
      • Archived Webcasts
      • Event Calendar
    • Corporate Governance
      • Board of Directors
      • Board Criteria
      • Director Compensation and Board Meeting Attendance
      • Committee Composition
      • Certificates of Incorporation
      • Bylaws
      • Code of Ethics
      • Clawback Policy
      • RSU Holding Guidelines
      • Annual Meeting
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
      • Ownership Profile
    • Financials
      • Annual Reports
      • SEC Filings
    • Shareholder Services
      • Investor FAQ
      • Information Request
    • Press Kit
  • Careers
    • Available Positions
      • Search Open Jobs
      • Browse Open Jobs
      • Edit Your Profile
      • View Submitted Applications
    • Culture & Core Principles
    • Benefits
    • Equal Opportunity
    • Intern Program
    • Post-Doctoral Program

News

April 20, 2018
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
More »
April 17, 2018
Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of Antisense Drugs for Neurological Diseases
More »
April 17, 2018
Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
More »
April 17, 2018
Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors
More »
Follow us on twitter
Ionis Spotlight

Spotlight

Ionis Pharmaceuticals Publishes Paper on Growth of RNA-targeted Therapeutics in Cell Metabolism
More »
IONIS NEURO-TTR Phase 3 Clinical Trial Highlighted at American College of Cardiology (ACC) Annual Meeting
More »
FDA Accepts Plazomicin’s NDA with Priority Review for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
More »
Ionis’ SPINRAZA Recognized with Prestigious Prix Galien Award for Best Biotechnology Product
More »
Ionis RSS Feed
Receive Spotlight Emails
Ionis Clinical Trials

Clinical Trials

We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »

Ionis Events Roundtable

Events

04-21-2018 - 04-27-2018
2018 AAN Annual Meeting
05-23-2018
Annual Meeting of Stockholders Webcast
  • Home
  • Contact
  • Terms of Use and Forward-Looking Statements
  • Privacy Policy
©1999 - 2018 Ionis Pharmaceuticals™ is a trademark of Ionis Pharmaceuticals, Inc. Akcea Therapeutics™ is a trademark of Ionis Pharmaceuticals, Inc.
  • About
    • Mission & Values
    • In The Community
    • Management
    • Board of Directors
    • Contact
  • R&D
    • Antisense Technology
      • Discovery Platform
      • Basic Science
      • Antisense Drugs
      • Medicinal Chemistry
      • Antisense Approaches
    • Intellectual Property
    • Strategic Alliances
      • Pharmaceutical Partners
      • Satellite Companies
  • Pipeline
  • Patients
    • Patient Resources
    • Clinical Trials
      • Drug Approval Process
  • Medical Professionals
    • ATTR Expanded Access Program
  • Investors & Media
    • News & Events
      • Press Releases
      • Archived Webcasts
      • Event Calendar
    • Corporate Governance
      • Board of Directors
      • Board Criteria
      • Director Compensation and Board Meeting Attendance
      • Committee Composition
      • Certificates of Incorporation
      • Bylaws
      • Code of Ethics
      • Clawback Policy
      • RSU Holding Guidelines
      • Annual Meeting
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
      • Ownership Profile
    • Financials
      • Annual Reports
      • SEC Filings
    • Shareholder Services
      • Investor FAQ
      • Information Request
    • Press Kit
  • Careers
    • Available Positions
      • Search Open Jobs
      • Browse Open Jobs
      • Edit Your Profile
      • View Submitted Applications
    • Culture & Core Principles
    • Benefits
    • Equal Opportunity
    • Intern Program
    • Post-Doctoral Program